title: Discordant expression of the cyclin-dependent kinases and cyclins in rat liver following acute administration of the hepatocarcinogen [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY14,643).
abstract: Cellular proliferation is an essential aspect of chemical carcinogenesis. At the core of cell cycle regulation is a family of serine/threonine protein kinases termed cyclin-dependent kinases (cdk). Cdk activity, which directs progression through the cell cycle, is dependent upon cdk binding to the appropriate, phase-specific cyclin proteins. Alterations in hepatic cdk1, cdk2, cdk4, cdk5, and cyclin protein expression were determined in response to acute dosing of the prototypic peroxisome proliferator and hepatocarcinogen [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY14,643). Intraperitoneal dosing of 45 mg WY14,643/kg daily for 4 days to young, male rats produced dramatic increases in hepatic protein expression of all cdk analyzed as well as cyclins B, D2, D3, and proliferating cell nuclear antigen (PCNA). The largest relative increases, 6.1-, 2.8-, 11-, 83-, and 7.9-fold, were seen with cdk1, cdk4, cyclin B, cyclin D3, and PCNA, respectively. Increases of only 1.8-, 2-, 1.6-, and 1.4-fold were noted, respectively, for cdk2, cdk5, cyclin D2, and cyclin E. Analysis of gel filtration fractions indicated that PCNA co-eluted with cdk1 from the WY14,643-treated rats as a 70-80 kDa molecular complex. In contrast, cdk4, cdk5 and D cyclins migrated as much larger complexes with an estimated MW of approximately 180-190 kDa.
authors.affiliation: Section of Cellular Physiology, Paracelsian, Inc., Ithaca, NY 14850, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Rininger
authors.forename: G D
authors.initials: GD
authors.lastname: Wheelock
authors.forename: X
authors.initials: X
authors.lastname: Ma
authors.forename: J G
authors.initials: JG
authors.lastname: Babish
mesh_terms: D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D018844:Cyclin-Dependent Kinases / Q000032:analysis*; D016213:Cyclins / Q000032:analysis*; D008099:Liver / Q000737:chemistry / Q000187:drug effects*; D008297:Male; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D011743:Pyrimidines / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D002273:Carcinogens; D016213:Cyclins; D018809:Proliferating Cell Nuclear Antigen; D011743:Pyrimidines; C006253:pirinixic acid; D018844:Cyclin-Dependent Kinases